Roche Continues to Pursue Ventana But Won't Raise Bid; MDx Revs Fall on Expired PCR IP | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Roche is pressing forward with its plans to acquire Ventana Medical Systems in a hostile takeover, but company officials said last week that they would not increase their offer of $75 per share.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.